New calogenin pregnane glycoside derivative from Huernia saudi- arabica and its Lipase and α-Glucosidase Inhibitory Activities.
Autor: | El Sayed AM; Pharmacognosy Department, College of Pharmacy, Cairo University, Kasr El-Einy Street, 11562, Cairo, Egypt. Electronic address: galbd_abeer@yahoo.com., AbdElSattar E; Pharmacognosy Department, College of Pharmacy, Cairo University, Kasr El-Einy Street, 11562, Cairo, Egypt. Electronic address: essam_abdelsattar@yahoo.com., Khalil MN; Pharmacognosy Department, College of Pharmacy, Cairo University, Kasr El-Einy Street, 11562, Cairo, Egypt. Electronic address: Mohamed.Nabil@pharma.cu.edu.eg. |
---|---|
Jazyk: | angličtina |
Zdroj: | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2020 Jul; Vol. 127, pp. 110143. Date of Electronic Publication: 2020 Apr 24. |
DOI: | 10.1016/j.biopha.2020.110143 |
Abstrakt: | As ongoing investigation of Huernia saudi-arabica D.V.Field (Asclepiadaceae), a new steroidal pregnane glycoside (Huernioside A) was isolated from dichloromethane fraction (DCM); it was identified as 3β, 11, 14β, 20(R)-tetrahydroxy-pregna-5,9(11)-diene-3-O-β-D-thevetopyranosyl-(1-4)-β-D-cymaropyranoside(HCP) through analysis of 1D, 2D NMR besides ESI-MS data. The alcoholic extract of the aerial part (ALE), DCM and HCP showed inhibitory potential against pancreatic lipase compared to orilstat. Among the tested samples, the ALE and HCP exhibited a promising pancreatic lipase inhibitory commotion through IC (Copyright © 2020. Published by Elsevier Masson SAS.) |
Databáze: | MEDLINE |
Externí odkaz: |